About NuclearPharm

NuclearPharm specializes in the development of innovative radiopharmaceuticals for both diagnostic imaging and therapeutic applications. With a focus on advancing the field of nuclear medicine, we are committed to delivering groundbreaking solutions to improve patient outcomes. In addition to our in-house drug development efforts, including our lead candidate NP-DCM-075 for Sentinel Lymph Node detection currently advancing to clinical trials, we also operate as a Contract Research Organization (CRO). Our CRO services include expert consultancy, preclinical study design, radiochemistry development, and in vitro and in vivo evaluations, providing comprehensive support to clients in the radiopharmaceutical sector.